Update on SARS-CoV-2
May 27th, 2020 : 14:00 CEST
IABS has been asked to organize several webinars in order to share scientific information on SARS-CoV-2.
As science is evolving day after day, it is important for many people to have an overview of the actual knowledge at a specific moment in time.
The first IABS webinar that took place Wednesday May 27th from 14:00-16:00 CEST gave you an insight to what is known about SARS-CoV-2, the epidemiology worldwide, the disease from an immunology viewpoint and where we are today with the development of vaccines against the virus.
This webinar is the first in a series of webinars to inform our network on what is known about the virus, the disease, and how to cope with it.
The recording of the webinar is available below:
IABS offers Open Access to its SARS-CoV-2 series of webinars
- Prof. Bruno Lina, professor of Virology, University Claude Bernard Lyon and Director of the research laboratory VirPath - slides - Replay
- Prof. Arnaud Fontanet, Director of the Department of Global Health, Head of the Emerging Diseases Epidemiology Unit, Institut Pasteur - slides - Replay
- Prof. Arnaud Marchant, Director of the Institute for Medical Immunology, Université Libre de Bruxelles - slides - Replay
- Dr. Melanie Saville, Head of Vaccine R&D, CEPI Vaccines - slides - Replay
The complete set of speakers slides are available here.
14:00 - Welcome & Introduction - Dr. Joris Vandeputte, President, IABS
14:05 - What do we know about the SARS-CoV-2 virus - Prof. Bruno Lina
14:20 - Epidemiology: the latest data on the pandemic - Prof. Arnaud Fontanet
14:35 - The disease from the viewpoint of an immunologist - Prof. Arnaud Marchant
14:50 - Vaccine development - where are we? - Dr. Melanie Saville
15:05 - Q&A
16:00 - End of webinar